Title: Ladouceur, Gaetan H. et al. Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters (2002), 12(23), 3421-3424.
20331-29-7 | N-(4-Sec-butylphenyl)-3-chloropropanamide | AA0028QS | MFCD02973804
203664-61-3 | tert-Butyl 4-(2,2-dibromovinyl)piperidine-1-carboxylate | AA0028ZW | MFCD20528891
204197-28-4 | Boc-dap(aloc)-oh dcha | AA00298X | MFCD00800348
2045-79-6 | Benzeneethanamine, 2-methoxy- | AA0029GJ | MFCD00008186
20503-40-6 | 6-Aminobenzo[b]thiophene 1,1-dioxide | AA0029QR | MFCD00173800
205432-12-8 | 1-Piperazinecarboxylic acid, 4-[2-(2,4-dinitrophenoxy)-1-oxidodiazenyl]-, ethyl ester | AA002A0L | MFCD06407868
2058-74-4 | N-Methylisatin | AA002AAP | MFCD00005812
19715-19-6 | 3,5-Bis-tert-butylsalicylic acid | AA002AJL | MFCD00059058
197632-83-0 | N-Me-ser(tbu)-oh | AA002AU4 | MFCD02094572
14338-82-0 | Dibutyl methylenebis(thioglycolate) | AA002B74 | MFCD00027216
1198286-07-5
167316-28-1
2023463-51-4
17899-45-5
1406591-40-9
1081129-13-6